L. Goldenberg, A. So, N. Fleshner, R. Rendon, D. Drachenberg, and M. Elhilali, “The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?”, CUAJ, vol. 3, no. 3-S2, pp. S109-S114, May 2013.